Browsing by Author "Toumi M."

Now showing 1 - 2 of 2
  • No Thumbnail Available
    Item
    ARIA digital anamorphosis: Digital transformation of health and care in airway diseases from research to practice
    (John Wiley and Sons Inc, 2021) Bousquet J.; Anto J.M.; Bachert C.; Haahtela T.; Zuberbier T.; Czarlewski W.; Bedbrook A.; Bosnic-Anticevich S.; Walter Canonica G.; Cardona V.; Costa E.; Cruz A.A.; Erhola M.; Fokkens W.J.; Fonseca J.A.; Illario M.; Ivancevich J.-C.; Jutel M.; Klimek L.; Kuna P.; Kvedariene V.; Le L.T.T.; Larenas-Linnemann D.E.; Laune D.; Lourenço O.M.; Melén E.; Mullol J.; Niedoszytko M.; Odemyr M.; Okamoto Y.; Papadopoulos N.G.; Patella V.; Pfaar O.; Pham-Thi N.; Rolland C.; Samolinski B.; Sheikh A.; Sofiev M.; Suppli Ulrik C.; Todo-Bom A.; Tomazic P.-V.; Toppila-Salmi S.; Tsiligianni I.; Valiulis A.; Valovirta E.; Ventura M.-T.; Walker S.; Williams S.; Yorgancioglu A.; Agache I.; Akdis C.A.; Almeida R.; Ansotegui I.J.; Annesi-Maesano I.; Arnavielhe S.; Basagaña X.; D. Bateman E.; Bédard A.; Bedolla-Barajas M.; Becker S.; Bennoor K.S.; Benveniste S.; Bergmann K.C.; Bewick M.; Bialek S.; E. Billo N.; Bindslev-Jensen C.; Bjermer L.; Blain H.; Bonini M.; Bonniaud P.; Bosse I.; Bouchard J.; Boulet L.-P.; Bourret R.; Boussery K.; Braido F.; Briedis V.; Briggs A.; Brightling C.E.; Brozek J.; Brusselle G.; Brussino L.; Buhl R.; Buonaiuto R.; Calderon M.A.; Camargos P.; Camuzat T.; Caraballo L.; Carriazo A.-M.; Carr W.; Cartier C.; Casale T.; Cecchi L.; Cepeda Sarabia A.M.; H. Chavannes N.; Chkhartishvili E.; Chu D.K.; Cingi C.; Correia de Sousa J.; Costa D.J.; Courbis A.-L.; Custovic A.; Cvetkosvki B.; D'Amato G.; da Silva J.; Dantas C.; Dokic D.; Dauvilliers Y.; De Feo G.; De Vries G.; Devillier P.; Di Capua S.; Dray G.; Dubakiene R.; Durham S.R.; Dykewicz M.; Ebisawa M.; Gaga M.; El-Gamal Y.; Heffler E.; Emuzyte R.; Farrell J.; Fauquert J.-L.; Fiocchi A.; Fink-Wagner A.; Fontaine J.-F.; Fuentes Perez J.M.; Gemicioğlu B.; Gamkrelidze A.; Garcia-Aymerich J.; Gevaert P.; Gomez R.M.; González Diaz S.; Gotua M.; Guldemond N.A.; Guzmán M.-A.; Hajjam J.; Huerta Villalobos Y.R.; Humbert M.; Iaccarino G.; Ierodiakonou D.; Iinuma T.; Jassem E.; Joos G.; Jung K.-S.; Kaidashev I.; Kalayci O.; Kardas P.; Keil T.; Khaitov M.; Khaltaev N.; Kleine-Tebbe J.; Kouznetsov R.; Kowalski M.L.; Kritikos V.; Kull I.; La Grutta S.; Leonardini L.; Ljungberg H.; Lieberman P.; Lipworth B.; Lodrup Carlsen K.C.; Lopes-Pereira C.; Loureiro C.C.; Louis R.; Mair A.; Mahboub B.; Makris M.; Malva J.; Manning P.; Marshall G.D.; Masjedi M.R.; Maspero J.F.; Carreiro-Martins P.; Makela M.; Mathieu-Dupas E.; Maurer M.; De Manuel Keenoy E.; Melo-Gomes E.; Meltzer E.O.; Menditto E.; Mercier J.; Micheli Y.; Miculinic N.; Mihaltan F.; Milenkovic B.; Mitsias D.I.; Moda G.; Mogica-Martinez M.-D.; Mohammad Y.; Montefort S.; Monti R.; Morais-Almeida M.; Mösges R.; Münter L.; Muraro A.; Murray R.; Naclerio R.; Napoli L.; Namazova-Baranova L.; Neffen H.; Nekam K.; Neou A.; Nordlund B.; Novellino E.; Nyembue D.; O'Hehir R.; Ohta K.; Okubo K.; Onorato G.L.; Orlando V.; Ouedraogo S.; Palamarchuk J.; Pali-Schöll I.; Panzner P.; Park H.-S.; Passalacqua G.; Pépin J.-L.; Paulino E.; Pawankar R.; Phillips J.; Picard R.; Pinnock H.; Plavec D.; Popov T.A.; Portejoie F.; Price D.; Prokopakis E.P.; Psarros F.; Pugin B.; Puggioni F.; Quinones-Delgado P.; Raciborski F.; Rajabian-Söderlund R.; Regateiro F.S.; Reitsma S.; Rivero-Yeverino D.; Roberts G.; Roche N.; Rodriguez-Zagal E.; Roller-Wirnsberger R.E.; Rosario N.; Romano A.; Rottem M.; Ryan D.; Salimäki J.; Sanchez-Borges M.M.; Sastre J.; Scadding G.K.; Scheire S.; Schmid-Grendelmeier P.; Schünemann H.J.; Sarquis Serpa F.; Shamji M.; Sisul J.-C.; Solé D.; Somekh D.; Sooronbaev T.; Sova M.; Spertini F.; Spranger O.; Stellato C.; Stelmach R.; Thibaudon M.; To T.; Toumi M.; Usmani O.; Valero A.A.; Valenta R.; Valentin-Rostan M.; Pereira M.U.; van der Kleij R.; Van Eerd M.; Vandenplas O.; Vasankari T.; Vaz Carneiro A.; Vezzani G.; Viart F.; Viegi G.; Wallace D.; Wagenmann M.; Wang D.Y.; Waserman S.; Wickman M.; Williams D.M.; Wong G.; Wroczynski P.; Yiallouros P.K.; Yusuf O.M.; Zar H.J.; Zeng S.; Zernotti M.E.; Zhang L.; Shan Zhong N.; Zidarn M.
    Digital anamorphosis is used to define a distorted image of health and care that may be viewed correctly using digital tools and strategies. MASK digital anamorphosis represents the process used by MASK to develop the digital transformation of health and care in rhinitis. It strengthens the ARIA change management strategy in the prevention and management of airway disease. The MASK strategy is based on validated digital tools. Using the MASK digital tool and the CARAT online enhanced clinical framework, solutions for practical steps of digital enhancement of care are proposed. © 2020 EAACI and John Wiley and Sons A/S. Published by John Wiley and Sons Ltd.
  • No Thumbnail Available
    Item
    The Allergic Rhinitis and Its Impact on Asthma (ARIA) Approach of Value-Added Medicines: As-Needed Treatment in Allergic Rhinitis
    (American Academy of Allergy, Asthma and Immunology, 2022) Bousquet J.; Toumi M.; Sousa-Pinto B.; Anto J.M.; Bedbrook A.; Czarlewski W.; Valiulis A.; Ansotegui I.J.; Bosnic-Anticevich S.; Brussino L.; Canonica G.W.; Cecchi L.; Cherrez-Ojeda I.; Chivato T.; Costa E.M.; Cruz A.A.; Del Giacco S.; Fonseca J.A.; Gemicioglu B.; Haahtela T.; Ivancevich J.C.; Jutel M.; Kaidashev I.; Klimek L.; Kvedariene V.; Kuna P.; Larenas-Linnemann D.E.; Lipworth B.; Morais-Almeida M.; Mullol J.; Papadopoulos N.G.; Patella V.; Pham-Thi N.; Regateiro F.S.; Rouadi P.W.; Samolinski B.; Sheikh A.; Taborda-Barata L.; Ventura M.T.; Yorgancioglu A.; Zidarn M.; Zuberbier T.
    Drug repurposing is a major field of value-added medicine. It involves investigating and evaluating existing drugs for new therapeutic purposes that address unmet healthcare needs. Several unmet needs in allergic rhinitis could be improved by drug repurposing. This could be game-changing for disease management. Current medications for allergic rhinitis are centered on continuous long-term treatment, and medication registration is based on randomized controlled trials carried out for a minimum of 14 days with adherence of 70% or greater. A new way of treating allergic rhinitis is to propose as-needed treatment depending on symptoms, rather than classical continuous treatment. This rostrum will discuss existing clinical trials on as-needed treatment for allergic rhinitis and real-world data obtained by the mobile health app MASK-air, which focuses on digitally-enabled, patient-centered care pathways. © 2022 American Academy of Allergy, Asthma & Immunology